Hydrocortisone - Topical
Monographie96produits
single · Topical
Noms acceptés (anglais)
417-Hydroxycorticosterone(common)Cortisol(common)Hydrocortisone(common)(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione(proper)
Noms acceptés (français)
417-Hydroxycorticosterone(common)Cortisol(common)Hydrocortisone(common)(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione(proper)
Allégations santé approuvées
4- For (the) temporary relief of itching associated with minor skin irritations, (inflammation) and rashes (due to eczema, insect bites, poison ivy, poison oak, poison sumac, seborrheic dermatitis, psoriasis, or contact with soaps, detergents, cosmetics or jewellery)
- For (the) temporary relief of external feminine genital itching and/or external anal itching (due to hemorrhoids)
- Antipruritic
- Anti-itch
Allégations santé approuvées (Français)
4- For (the) temporary relief of itching associated with minor skin irritations, (inflammation) and rashes (due to eczema, insect bites, poison ivy, poison oak, poison sumac, seborrheic dermatitis, psoriasis, or contact with soaps, detergents, cosmetics or jewellery)
- For (the) temporary relief of external feminine genital itching and/or external anal itching (due to hemorrhoids)
- Antipruritic
- Anti-itch
Plages de doses approuvées
1| Population | Plage de doses | Fréquence |
|---|---|---|
| Products for external feminine genital or anal itching | 0.25–1 % | — |
Mises en garde et contre-indications
7cautionFor external use only (US FDA 2023; HC 1985).
cautionWhen using this product avoid contact with the eyes. If contact occurs, rinse thoroughly with water (US FDA 2023).
cautionStop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist for more than 7 days, worsen, or re-occur within a few days (US FDA 2023; HC 1985).
cautionKeep out of reach of children. If swallowed, call a poison control centre or get medical help right away.
contraindicationDo not use for the treatment of diaper rash (US FDA 2023; Berardi et al. 2002).
contraindicationDo not use if you have a vaginal discharge (US FDA 2023; HC 1985).
adverse_reactionStop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience bleeding (US FDA 2023).
Ingrédients couverts
4Validez contre la monographie Hydrocortisone - Topical
Vérifiez si votre produit respecte toutes les exigences de la monographie Hydrocortisone - Topical — doses, allégations, mises en garde et étiquettes bilingues.
Analyser gratuitement